Opportunities and challenges of active immunotherapy in dogs with B-cell lymphoma: a 5-year experience in two veterinary oncology centers

BACKGROUND: Pet dogs spontaneously develop lymphoma. An anthracycline-based multidrug chemotherapy regimen represents the treatment cornerstone; however, cure is rarely achieved. We have been treating dogs with B-cell lymphoma with an autologous vaccine (APAVAC®) and CHOP-based chemotherapy since 20...

Descripción completa

Detalles Bibliográficos
Autores principales: Marconato, Laura, Aresu, Luca, Stefanello, Damiano, Comazzi, Stefano, Martini, Valeria, Ferrari, Roberta, Riondato, Fulvio, Rouquet, Nicole, Frayssinet, Patrick, Sabattini, Silvia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554898/
https://www.ncbi.nlm.nih.gov/pubmed/31174615
http://dx.doi.org/10.1186/s40425-019-0624-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554898/
https://www.ncbi.nlm.nih.gov/pubmed/31174615
http://dx.doi.org/10.1186/s40425-019-0624-y

Ejemplares similares